Search

everythinglearnresearchcommunity

for

Search:↓

Active treatment can help prevent scarring hair loss in SLE patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

SLE and DM can coexist but are rare and need careful evaluation.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

A thorough, team-based approach and clear communication improve outcomes in complex neuropsychiatric lupus cases.

The 2012 criteria are better for diagnosing atypical lupus cases.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.